|
Session Title |
Talk Title |
View |
Curriculum Ref |
2650 |
Pulmonary arterial hypertension: what the cardiologist needs to know |
Aetiology of pulmonary hypertension |
|
|
2331 |
Pulmonary arterial hypertension: what the cardiologist needs to know |
Assessment and management of pulmonary hypertension |
|
|
2334 |
Inherited cardiac conditions |
Inherited aortopathies |
|
|
2335 |
Inherited cardiac conditions |
Inherited arrhythmias |
|
|
2336 |
Inherited cardiac conditions |
Inherited neurological diseases that affect the heart |
|
|
2640 |
SAC and training in ACHD |
BJCA survey (15 mins) |
|
|
2626 |
SAC and training in ACHD |
Inherited cardiac conditions (15 minutes) |
|
|
2628 |
SAC and training in ACHD |
SAC update (15 minutes) |
|
|
2629 |
SAC and training in ACHD |
Q & A (30 minutes) |
|
|
2341 |
Call the cardiology registrar..... |
Case 1: Management of ACS with multiple co-morbidities |
|
|
2342 |
Call the cardiology registrar..... |
Case 2: Management of refractory VT |
|
|
2345 |
'Future perspectives' - New imaging techniques in acquired heart disease |
What can echo offer? |
|
|
2346 |
'Future perspectives' - New imaging techniques in acquired heart disease |
What can CMR offer? |
|
|
2347 |
'Future perspectives' - New imaging techniques in acquired heart disease |
What can MPS/PET offer? |
|
|
2348 |
'Future perspectives' - New imaging techniques in acquired heart disease |
What can CCT offer? |
|
|
2351 |
'Quality Assurance' in cardiac imaging services - how will it be achieved, demonstrated and maintained in 'Tomorrow's World'? |
The Echo perspective |
|
|
2352 |
'Quality Assurance' in cardiac imaging services - how will it be achieved, demonstrated and maintained in 'Tomorrow's World'? |
The CMR perspective |
|
|
2353 |
'Quality Assurance' in cardiac imaging services - how will it be achieved, demonstrated and maintained in 'Tomorrow's World'? |
The MPS perspective |
|
|
2368 |
State of the art imaging in complex congenital heart disease - 'Tomorrow's World' |
Cardiac CT - under utilised: what can it offer? |
|
|
2369 |
State of the art imaging in complex congenital heart disease - 'Tomorrow's World' |
Future echo applications? |
|
|
2373 |
TAVI - implications of multi-modality imaging in patient selection, procedural guidance, and outcomes |
Role of imaging - pre-procedural evaluation |
|
|
2374 |
TAVI - implications of multi-modality imaging in patient selection, procedural guidance, and outcomes |
Role of imaging - guiding the procedure |
|
|
2375 |
TAVI - implications of multi-modality imaging in patient selection, procedural guidance, and outcomes |
Role of imaging - evaluation of outcomes |
|
|
2376 |
TAVI - implications of multi-modality imaging in patient selection, procedural guidance, and outcomes |
What the TAVI operator really wants to know from imaging? |
|
|
2381 |
What does imaging add to device therapy (ICD/CRT) - case selection & implantation technique? |
Overview of current ICD/CRT trials and guidelines |
|
|
2382 |
What does imaging add to device therapy (ICD/CRT) - case selection & implantation technique? |
Echo - what can it add? |
|
|
2383 |
What does imaging add to device therapy (ICD/CRT) - case selection & implantation technique? |
CMR - what can it add? |
|
|
2384 |
What does imaging add to device therapy (ICD/CRT) - case selection & implantation technique? |
Summary - evidence, on-going trials, and the future role of imaging |
|
|
2387 |
Ischaemia and viability assessment to guide complex revascularisation decisions |
Reliability of ischaemia detection in complex MVD (SPECT, CMR, DSE) |
|
|
2388 |
Ischaemia and viability assessment to guide complex revascularisation decisions |
Reliability of ischaemia detection in LMS stenosis (SPECT, CMR, DSE) |
|
|
2389 |
Ischaemia and viability assessment to guide complex revascularisation decisions |
On-going trials with the potential to change future practice? |
|
|
2391 |
Non-drug options for AF |
'Ablate and pace' - still relevant in 2014? |
|
|
2392 |
Non-drug options for AF |
Cardioversion - for whom and by whom? |
|
|
2393 |
Non-drug options for AF |
AF surgery - the 'norm' or a waste of time? |
|
|
2394 |
Non-drug options for AF |
AF Ablation - ok if it works, but where and how much? |
|
|
2398 |
Endocarditis - Optimal management and imaging strategy |
BSAC guidelines on the management of endocarditis |
|
|
2399 |
Endocarditis - Optimal management and imaging strategy |
TTE and TOE in left-sided endocarditis |
|
|
2400 |
Endocarditis - Optimal management and imaging strategy |
TTE and TOE in right-sided endocarditis |
|
|
2401 |
Endocarditis - Optimal management and imaging strategy |
Timing of surgery: intervene now or wait (for what)? |
|
|
2630 |
Genotype/phenotype correlation in familial sudden cardiac death syndromes |
Long QT syndrome |
|
|
2634 |
Genotype/phenotype correlation in familial sudden cardiac death syndromes |
HCM |
|
|
2658 |
Genotype/phenotype correlation in familial sudden cardiac death syndromes |
ARVC |
|
|
2404 |
Controversies in aortic valve disease |
Little old ladies heart - assessing the patient with low gradient severe AS |
|
|
2405 |
Controversies in aortic valve disease |
Mild to moderate AS in a patient undergoing CABG - replace or leave? |
|
|
2406 |
Controversies in aortic valve disease |
Patient prosthesis mismatch - what is it and are we bothered? |
|
|
2408 |
Controversies in aortic valve disease |
TAVI in lower risk patients - why we need trials? |
|
|
2423 |
Electrophysiology in adult congenital heart disease |
The burden of arrhythmic disease in the ACHD population? |
|
|
2424 |
Electrophysiology in adult congenital heart disease |
The nature of arrhythmias in ACHD - substrates and patterns |
|
|
2425 |
Electrophysiology in adult congenital heart disease |
The initial acute management of arrhythmias in ACHD patients |
|
|
2426 |
Electrophysiology in adult congenital heart disease |
Transcatheter treatment of arrhythmia in ACHD? |
|
|
2429 |
'Tomorrow's world' in interventional cardiology - New 'practice changing' technologies |
Aortic valve intervention - pushing the envelope |
|
|
2430 |
'Tomorrow's world' in interventional cardiology - New 'practice changing' technologies |
Mitral valve intervention - emerging technologies |
|
|
2431 |
'Tomorrow's world' in interventional cardiology - New 'practice changing' technologies |
Stroke prevention - a no brainer? |
|
|
2432 |
'Tomorrow's world' in interventional cardiology - New 'practice changing' technologies |
Absorbable stents - ready for clinical practice? |
|
|
2803 |
BCS/Mayo Clinic joint session - Innovations in circulatory failure, heart rhythm disorders and multi-modality imaging |
|
|
|
2825 |
BCS/Mayo Clinic joint session - Innovations in circulatory failure, heart rhythm disorders and multi-modality imaging |
|
|
|
2827 |
BCS/Mayo Clinic joint session - Innovations in circulatory failure, heart rhythm disorders and multi-modality imaging |
|
|
|
2434 |
Heart failure with normal ejection fraction |
What are HeFNEF/HePEF/diastolic heart failure? |
|
|
2435 |
Heart failure with normal ejection fraction |
Echocardiographic features of 'diastolic dysfunction' |
|
|
2436 |
Heart failure with normal ejection fraction |
Clinical trials to date - what went wrong? |
|
|
2437 |
Heart failure with normal ejection fraction |
Aldosterone antagonism for HeFNEF- does TOPCAT live up to its name? |
|
|
2507 |
Primary PCI - should we change our practice? |
Oracle: 'PRAMI' Trial (10 mins) |
|
|
2513 |
Primary PCI - should we change our practice? |
Oracle: 'TASTE' Trial (10 mins) |
|
|
2519 |
Primary PCI - should we change our practice? |
Oracle: 'SHOCK II' Trial (10 mins) |
|
|
2524 |
Primary PCI - should we change our practice? |
Oracle (10 mins) |
|
|
2451 |
Asymptomatic valve disease - surveillance and when to intervene |
Aortic regurgitation |
|
|
2452 |
Asymptomatic valve disease - surveillance and when to intervene |
Mitral regurgitation |
|
|
2458 |
'Tomorrow's world' - in imaging, and the Michael Davies Early Career Award |
Epicardial fat imaging by CT - a neglected modifiable risk factor? |
|
|
2459 |
'Tomorrow's world' - in imaging, and the Michael Davies Early Career Award |
Application of positron emission tomography to predict heart attack |
|
|
2647 |
'Tomorrow's world' - in imaging, and the Michael Davies Early Career Award |
The Michael Davies Early Career Award 2014 - The relevance of monogenic cardiovascular disorders to fundamental biology and drug discovery |
|
|
2655 |
'Tomorrow's world' - in cardiac rhythm management |
Spirals and rotors - a new target for AF ablation |
|
|
2463 |
'Tomorrow's world' - in cardiac rhythm management |
Subcutaneous ICDs - are transvenous systems still needed? |
|
|
2464 |
'Tomorrow's world' - in cardiac rhythm management |
Leadless pacing - the new frontier of cardiac pacing |
|
|
2467 |
Systems biology and -omics for the cardiologist |
Genomics |
|
|
2469 |
Systems biology and -omics for the cardiologist |
Proteomics - lipidomics profiling and risk of cardiovascular disease |
|
|
2472 |
'Tomorrow's world' in acute coronary syndromes |
Refining the diagnosis - new diagnostic biomarkers |
|
|
2473 |
'Tomorrow's world' in acute coronary syndromes |
Lesion evaluation |
|
|
2474 |
'Tomorrow's world' in acute coronary syndromes |
Bystander lesions in Primary PCI - lessons from PRAMI |
|
|
2476 |
Regenerative therapy - back to basics |
Using inducible pluripotent stem cells to study cardiovascular disease |
|
|
2477 |
Regenerative therapy - back to basics |
Regenerating the heart from the inside |
|
|
2478 |
Regenerative therapy - back to basics |
Transplantation of stem cells for heart failure |
|
|
2479 |
Joint BCS/ESC session: ESC guidelines for 'Stable CAD' and 'Diabetes and cardiovascular diseases' |
Diabetes, pre-diabetes and cardiovascular diseases - Guidelines |
|
|
2482 |
Joint BCS/ESC session: ESC guidelines for 'Stable CAD' and 'Diabetes and cardiovascular diseases' |
Stable coronary artery disease - Guidelines |
|
|
2579 |
Joint BCS/ESC session: ESC guidelines for 'Stable CAD' and 'Diabetes and cardiovascular diseases' |
Stable coronary artery disease - Implications and implementation in the UK |
|
|
2580 |
Joint BCS/ESC session: ESC guidelines for 'Stable CAD' and 'Diabetes and cardiovascular diseases' |
Diabetes, pre-diabetes and cardiovascular diseases - Implications and implementation in the UK |
|
|
2485 |
Cardiovascular outcomes - you can't live without them! |
Cardiovascular outcomes - great for the doctor, not for the patient |
|
|
2486 |
Cardiovascular outcomes - you can't live without them! |
Cardiovascular outcomes - great for the patient, not for the doctor |
|
|
2487 |
Cardiovascular outcomes - you can't live without them! |
Risk adjusted hospital outcomes in ACS - MINAP with muscles |
|
|
2488 |
Cardiovascular outcomes - you can't live without them! |
Cardiovascular outcomes - patient related outcome measures |
|
|
2491 |
Conditioning the heart by remote ischaemic pre-conditioning |
Protecting STEMI patients against myocardial infarction |
|
|
2492 |
Conditioning the heart by remote ischaemic pre-conditioning |
Protecting CABG patients agains peri-operative myocardial injury |
|
|
2493 |
Conditioning the heart by remote ischaemic pre-conditioning |
Protecting PCI patients against peri-procedural myocardial injury |
|
|
2496 |
'Tomorrow's world' in cardiomyopathy |
Preventing the progression of ARVC - the role of exercise and preload reduction |
|
|
2497 |
'Tomorrow's world' in cardiomyopathy |
Peripartum cardiomyopathy - novel therapeutic targets and biomarkers |
|
|
2498 |
'Tomorrow's world' in cardiomyopathy |
Cardiac amyloidosis - MRI diagnosis and new treatments |
|
|